What is the appropriate diagnostic and therapeutic approach for a pregnant patient with pyrexia of unknown origin (PUO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Approach to Pregnant Patient with PUO

In a pregnant patient with pyrexia of unknown origin, begin with ultrasound as the primary imaging modality, followed by MRI without contrast if ultrasound is nondiagnostic, while avoiding CT and nuclear medicine studies due to radiation exposure to the fetus.

Initial Clinical Assessment

Focus your history and examination on:

  • Gestation-specific infections: Urinary tract infections (most common in pregnancy), chorioamnionitis, pyelonephritis
  • Obstetric complications: Preterm prelabor rupture of membranes (PPROM), placental abnormalities
  • Thromboembolic disease: Deep vein thrombosis or pulmonary embolism (4-6 fold increased risk in pregnancy) 1
  • Endemic infections: Tuberculosis (especially extrapulmonary), enteric fever if relevant travel history
  • Signs of systemic inflammation: Lymphadenopathy, hepatosplenomegaly, joint involvement

Diagnostic Algorithm

Step 1: Laboratory Evaluation

  • Complete blood count with differential
  • Blood cultures (multiple sets)
  • Urinalysis and urine culture
  • Inflammatory markers (CRP, ESR)
  • Liver and renal function tests
  • Consider tuberculosis testing if endemic area or risk factors

Step 2: Initial Imaging - Ultrasound

Ultrasound is the first-line imaging modality for pregnant patients with fever 2:

  • US kidneys and bladder with color Doppler: Evaluate for pyelonephritis, renal abscess, hydronephrosis, urolithiasis
  • US abdomen: Assess for hepatobiliary pathology, splenic abnormalities, lymphadenopathy
  • Obstetric ultrasound: Evaluate fetal well-being, amniotic fluid, placental abnormalities

The main limitation is lower sensitivity compared to CT for detecting renal abscesses and small stones 2.

Step 3: Advanced Imaging if Ultrasound Nondiagnostic

MRI without IV contrast is the preferred advanced imaging 2:

  • MRI abdomen and pelvis without contrast: Can detect pyelonephritis, renal abscesses, hydronephrosis, pyonephrosis, and inflammatory conditions
  • Diffusion-weighted imaging (DWI): Useful for detecting pyelonephritis and abscesses without contrast
  • Avoid gadolinium-based contrast agents unless the indication is critical and benefits clearly outweigh unknown fetal risks 2

CT imaging is NOT supported as initial or routine imaging in pregnant patients due to ionizing radiation exposure to both fetus and mother 2.

Step 4: Targeted Investigations Based on Clinical Suspicion

For suspected pulmonary embolism (if respiratory symptoms present):

  • Chest X-ray first (low radiation dose) 3
  • If CXR normal: V/Q scan preferred over CTPA (lower maternal radiation dose: 0.98-1.07 mGy vs 10-60 mGy) 3
  • If CXR abnormal: CTPA may be considered 3

For suspected deep vein thrombosis:

  • Bilateral compression ultrasound of lower extremities 3
  • If positive, treat with anticoagulation
  • If negative with high suspicion, proceed to pulmonary vascular imaging

Empirical Management Considerations

Antibiotic Therapy

If urinary tract infection or pyelonephritis suspected (most common infectious cause in pregnancy):

  • Start empirical broad-spectrum antibiotics
  • 7-day course: IV ampicillin + erythromycin for 48 hours, then oral amoxicillin + erythromycin for 5 days 4
  • Azithromycin can substitute for erythromycin if unavailable 4
  • Avoid amoxicillin-clavulanic acid (associated with necrotizing enterocolitis) 4

Thromboprophylaxis

If hospitalized with PUO, consider VTE prophylaxis 1:

  • Weight-adjusted LMWH unless active bleeding, platelets <30 × 10⁹/L, or imminent delivery
  • Prolonged PT/APTT is NOT a contraindication to thromboprophylaxis 1
  • Continue for 10-14 days minimum after discharge; extend throughout pregnancy and postpartum if severe disease or third trimester 1

Critical Pitfalls to Avoid

  1. Do not defer ultrasound based on assumption that imaging won't be helpful—it remains the safest and often diagnostic modality
  2. Do not use CT as first-line imaging—radiation exposure is unjustified when safer alternatives exist 2
  3. Do not use nuclear medicine studies (DMSA, MAG3 scans)—not beneficial and involve radiation 2
  4. Do not withhold thromboprophylaxis due to coagulopathy labs alone—assess bleeding risk clinically 1
  5. Do not forget obstetric causes—degenerating fibroids, chorioamnionitis, PPROM can all present as PUO 5, 4

When Diagnosis Remains Elusive

If extensive workup remains negative:

  • Bone marrow examination may be considered, particularly if cytopenias, splenomegaly, or concern for hematologic malignancy 6
  • Empirical anti-tuberculosis therapy trial if high endemic area and suggestive features
  • Close monitoring: Up to 50% of PUO cases remain undiagnosed, but undiagnosed cohorts generally have good prognosis 7, 8
  • Multidisciplinary consultation: Maternal-fetal medicine, infectious disease, and hematology input

The key principle is radiation avoidance while maintaining diagnostic rigor—ultrasound and MRI without contrast provide excellent diagnostic capability for most pregnancy-related and systemic causes of fever without fetal risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.